Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2022. Start Trial.
Date Value
November 13, 2026 9.042B
November 12, 2026 9.042B
November 11, 2026 8.635B
November 10, 2026 8.635B
November 09, 2026 8.635B
November 06, 2026 7.554B
November 05, 2026 7.554B
November 04, 2026 7.554B
November 03, 2026 7.554B
November 02, 2026 7.554B
October 30, 2026 7.554B
October 29, 2026 7.554B
October 28, 2026 7.554B
October 27, 2026 7.554B
October 26, 2026 7.554B
October 23, 2026 7.554B
October 22, 2026 7.554B
October 21, 2026 7.554B
October 20, 2026 7.554B
October 19, 2026 7.554B
October 16, 2026 7.554B
October 15, 2026 7.554B
October 14, 2026 7.554B
October 13, 2026 7.554B
October 12, 2026 7.554B
Date Value
October 09, 2026 7.554B
October 08, 2026 7.554B
October 07, 2026 7.107B
October 06, 2026 7.107B
October 05, 2026 7.107B
October 02, 2026 7.107B
October 01, 2026 7.107B
September 30, 2026 7.107B
September 29, 2026 7.454B
September 28, 2026 7.454B
September 25, 2026 7.454B
September 24, 2026 7.454B
September 23, 2026 7.454B
September 22, 2026 7.454B
September 21, 2026 7.454B
September 18, 2026 7.454B
September 17, 2026 7.454B
September 16, 2026 7.454B
September 15, 2026 7.454B
September 14, 2026 7.838B
September 11, 2026 7.613B
September 10, 2026 6.604B
September 09, 2026 6.604B
September 08, 2026 6.604B
September 04, 2026 6.604B

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Novo Nordisk A/S 152.68B
ALK-Abello A/S 7.898B
AstraZeneca PLC 598.40B
ANI Pharmaceuticals, Inc. 1.807B
Corcept Therapeutics, Inc. 7.615B